428 related articles for article (PubMed ID: 19540364)
1. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
2. The immune response to citrullinated antigens in autoimmune diseases.
Migliorini P; Pratesi F; Tommasi C; Anzilotti C
Autoimmun Rev; 2005 Nov; 4(8):561-4. PubMed ID: 16214096
[TBL] [Abstract][Full Text] [Related]
3. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
4. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
5. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis.
Yamada R
Autoimmun Rev; 2005 Apr; 4(4):201-6. PubMed ID: 15893712
[TBL] [Abstract][Full Text] [Related]
8. The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.
Hung HC; Lin CY; Liao YF; Hsu PC; Tsay GJ; Liu GY
Apoptosis; 2007 Mar; 12(3):475-87. PubMed ID: 17216583
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
Yamada R; Suzuki A; Chang X; Yamamoto K
Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
[TBL] [Abstract][Full Text] [Related]
10. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.
Suzuki A; Yamada R; Chang X; Tokuhiro S; Sawada T; Suzuki M; Nagasaki M; Nakayama-Hamada M; Kawaida R; Ono M; Ohtsuki M; Furukawa H; Yoshino S; Yukioka M; Tohma S; Matsubara T; Wakitani S; Teshima R; Nishioka Y; Sekine A; Iida A; Takahashi A; Tsunoda T; Nakamura Y; Yamamoto K
Nat Genet; 2003 Aug; 34(4):395-402. PubMed ID: 12833157
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.
Auger I; Martin M; Balandraud N; Roudier J
Arthritis Rheum; 2010 Jan; 62(1):126-31. PubMed ID: 20039406
[TBL] [Abstract][Full Text] [Related]
13. ABAP: antibody-based assay for peptidylarginine deiminase activity.
Zendman AJ; Raijmakers R; Nijenhuis S; Vossenaar ER; Tillaart Mv; Chirivi RG; Raats JM; van Venrooij WJ; Drijfhout JW; Pruijn GJ
Anal Biochem; 2007 Oct; 369(2):232-40. PubMed ID: 17716614
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker.
Nijenhuis S; Zendman AJ; Vossenaar ER; Pruijn GJ; vanVenrooij WJ
Clin Chim Acta; 2004 Dec; 350(1-2):17-34. PubMed ID: 15530456
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Bodil Roth E; Theander E; Londos E; Sandberg-Wollheim M; Larsson A; Sjöberg K; Stenberg P
Scand J Immunol; 2008 Jun; 67(6):626-31. PubMed ID: 18476880
[TBL] [Abstract][Full Text] [Related]
16. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
[TBL] [Abstract][Full Text] [Related]
17. Citrullination: a posttranslational modification in health and disease.
György B; Tóth E; Tarcsa E; Falus A; Buzás EI
Int J Biochem Cell Biol; 2006; 38(10):1662-77. PubMed ID: 16730216
[TBL] [Abstract][Full Text] [Related]
18. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.
Chang X; Han J
Mol Carcinog; 2006 Mar; 45(3):183-96. PubMed ID: 16355400
[TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
20. Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene.
Horikoshi N; Tachiwana H; Saito K; Osakabe A; Sato M; Yamada M; Akashi S; Nishimura Y; Kagawa W; Kurumizaka H
Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):112-8. PubMed ID: 21245532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
